Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,152 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06727721RecruitingPhase 2
Stem cell therapy for hard-to-treat type 2 diabetes
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
ShanghaiAges 18–70 - NCT07512934Recruiting
Pancreatic Function Study in Early Type 2 Diabetes
This study examines how the pancreas works in people newly diagnosed with type 2 diabetes. Researchers will assess pancreatic function to better understand early diabetes and potentially improve treatment.
Aktobe, AktobeAges 18–74 - NCT07502508RecruitingPhase 2
Icovamenib for type 2 diabetes with Ozempic
This trial tests an investigational pill called icovamenib for people with type 2 diabetes who are already on Ozempic but still have high blood sugar. The goal is to see if adding icovamenib helps lower blood sugar more safely.
Birmingham, AlabamaAges 18–70 - NCT06082063RecruitingPhase 3
Reducing heart disease risk in type 1 diabetes
This trial tests a combination of treatments to lower the risk of heart disease and kidney problems in people with type 1 diabetes who already have some complications or higher risk. If you qualify, you will receive extra care aimed at preventing heart attacks, strokes, and kidney failure.
CopenhagenAges 40–90 - NCT07483879Recruiting
Organ Injury Biomarkers in Newly Diagnosed Type 1 Diabetes
This study looks at signs of acute organ injury in children newly diagnosed with type 1 diabetes. It aims to understand how the body reacts to diabetes and its treatment, which could help improve care for kids like yours.
Thessaloniki, Central MakedoniaAges 2–16 - NCT06331338Recruiting
Decision cycle for better blood sugar control in type 2 diabetes
This study tests a new way to help people with type 2 diabetes make decisions about their blood sugar control. The goal is to see if this approach can improve your diabetes management.
HsinchuAges 18 years+ - NCT07373938Recruiting
Carotid Artery Texture and Heart Risk in Type 2 Diabetes
This study uses a neck ultrasound to look at the texture of your carotid artery (a main blood vessel in your neck) to find early signs of heart and blood vessel risk. It is for adults with type 2 diabetes who have not already had a heart attack or stroke.
Elche, AlicanteAges 40–69 - NCT03761446Recruiting
Testing how diabetes affects muscle loss after bed rest
This study looks at how pre-diabetes or type 2 diabetes may change skeletal muscle loss and recovery in older adults after a period of bed rest. It may help researchers understand why recovery can be slower and how to better protect muscle in people as they age.
Orlando, FloridaAges 60–80 - NCT07262788Recruiting
Lifestyle program for recently diagnosed type 2 diabetes
This study tests whether a carefully guided lifestyle program (diet and exercise) can help people who were recently diagnosed with type 2 diabetes achieve remission—meaning their blood sugar stays normal without medication. You may be a good fit if you are overweight, not on insulin, and have had diabetes for less than 6 years.
Herlev, DenmarkAges 18–75 - NCT07252765Recruiting
Nutritional Drink for Diabetes with Malnutrition Risk
This study is testing whether a special diabetes drink (high in calories, protein, and fiber) helps people with type 2 diabetes who are at risk of malnutrition. If you have diabetes and have been prescribed this drink, you may be able to join.
Santander, CantabriaAges 18 years+ - NCT06902597Recruiting
Sarcopenia and nerve damage in type 1 diabetes: a pilot study
This study looks at whether muscle loss (sarcopenia) is related to diabetic nerve damage in adults with type 1 diabetes. If you join, you will help researchers understand this connection better.
Rome, LazioAges 50–80 - NCT07248891Enrolling by invitation
Type 2 diabetes study in Mexico
This study looks at factors related to type 2 diabetes in adults receiving care at family medicine clinics in three Mexican states. It may help improve understanding of diabetes management.
Mexico City, Mexico CityAges 18 years+ - NCT07216118Recruiting
Helping teens with type 2 diabetes and their families
This study tests ways to help teens and young adults with type 2 diabetes and their families deal with social needs (like food, housing, or money challenges) that can affect health. You and a parent or caregiver will join together.
Pittsburgh, PennsylvaniaAges 13 years+ - NCT07142252RecruitingPhase 2
New drug for recently diagnosed type 1 diabetes
This trial tests a new medicine (rezpegaldesleukin) to see if it can help preserve the body's ability to make some insulin in people recently diagnosed with type 1 diabetes. It's for children and adults diagnosed within the past 100 days.
San Francisco, CaliforniaAges 8–45 - NCT07129915Recruiting
Can a smartphone nudge improve diabetes self-management?
This trial tests whether using a nudge-based digital tool (on your smartphone) helps people with type 2 diabetes make better decisions and manage their condition more effectively at home.
Xiamen, FujianAges 18 years+ - NCT07088068RecruitingPhase 3
Teplizumab for newly diagnosed type 1 diabetes
This study tests whether teplizumab can help keep the body making insulin in people recently diagnosed with type 1 diabetes. It is for children and young adults aged 1 to 25, and compares the drug against a placebo.
Scottsdale, ArizonaAges 1–25 - NCT06152588Recruiting
Time-restricted eating for type 2 diabetes
This trial tests if eating only during a restricted time window each day can help control blood sugar in people with type 2 diabetes. If you have type 2 diabetes, are overweight, and usually eat over a long period each day, you may be able to join.
Herlev, DenmarkAges 18 years+ - NCT07062887Recruiting
Digital mindfulness for young adults with type 1 diabetes
This study tests a digital mindfulness program designed to help young adults manage the stress of living with type 1 diabetes. If you are between 18 and 30, use a continuous glucose monitor, and have a smartphone, you may be able to join.
New Haven, ConnecticutAges 18–30 - NCT07054125Recruiting
CGM, education, and peer support for type 2 diabetes
This trial tests if using a continuous glucose monitor (a small sensor that tracks your blood sugar), combined with diabetes education and support from others with diabetes, can help people with type 2 diabetes better control their blood sugar. You may qualify if your blood sugar is not well controlled (A1c above 8%).
Asheville, North CarolinaAges 18 years+ - NCT07037810Enrolling by invitation
Comparing two ways to match insulin to meals in type 1 diabetes
This study tests two methods for deciding how much insulin to take with meals: counting exact carbohydrates or using a simpler meal-size guide. It aims to see which approach works best for people with type 1 diabetes who already use multiple daily injections and have moderate to high blood sugar levels (HbA1c 7.5% to under 11%).
Kuwait CityAges 21 years+ - NCT07017127Recruiting
Remission of type 2 diabetes with lifestyle changes
This trial tests whether a lifestyle program can help people recently diagnosed with type 2 diabetes achieve remission. It focuses on diet and physical activity, not medications.
SplitAges 20–69 - NCT06972732RecruitingPhase 4
Comparing three diabetes drugs for type 2 diabetes
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
Seoul, Seocho DistrictAges 19 years+ - NCT06319560Recruiting
Hydroxychloroquine for type 2 diabetes during pregnancy
This study tests if hydroxychloroquine, a medicine sometimes used for autoimmune conditions, can help control blood sugar in pregnant women with type 2 diabetes. It aims to improve pregnancy outcomes for both mother and baby.
Cheras, Kuala LumpurAges 20–45 - NCT06906640Recruiting
Improving Kidney Care for People with Type 2 Diabetes
This study tests a program to help primary care doctors better screen and manage kidney problems in people with type 2 diabetes. It aims to see if using recommended medicines can slow kidney disease and improve health.
Birmingham, AlabamaAges 18 years+
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,152 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.